New Treatments May Extend Pancreatic Cancer Survival

This news article has expired. Below you will find a short description about the news article and comments that were left by CancerCompass users.



Fri Jul 27, 2018 07:13 PM

Is FU-5 a single drug or part of a cocktail?  I have a sister undergoing chemotherapy for Stage 4 pancreatic cancer that has metastisized to the liver.  The problem with her treatment is she also has Lupus (SLE) and doesn't qualify for many of the clinical trials.

Thu Aug 16, 2018 04:25 PM

My Mom had this treatment in 2011 - it's not new. I'm guessing the trials for this are now being published. 

Thu Oct 11, 2018 05:28 PM

I am 24 months post-modified Whipple (the tail of my pancreas was not removed nor any of my stomach). Following surgery I had 3 months of Gemzar chemo at a relatively high dose. I do not have diabetes, high blood pressure, diarrhea, nor am I overweight. My gastroenterologist says I am the healthiest post-Whipple patient he has ever seen.

     I have had multiple tests, including 4 or 5 PET scans, all negative; however, this article causes me to wonder if I should assume pancreatic cancer will recur somewhere in my body.

     Obviously there are pancreatic cancer survivors in the 5 percent who do not die of it, and I am hoping that I am one of them.

Sun Jan 13, 2019 08:36 AM

My father had this in 2014. This is not new right

Mon Mar 11, 2019 01:04 AM

My husband has inoperable (per Mayo) Pancreatic cancer in the head and mets (2) to the liver - Stage 4. He just had #4 infusion of Fulfirinox. His Ca-19-9 went from 5,000 and last week was 1720. He's managing pretty well. We are now investigating the Nanoknife IRE procedure and the doctor wants him to have 6 Folfirinox infusions. Anyone had this, and is it covered by medicare insurance? I'm trying to figure this out, and appreciate help. Thank you! 

You must be logged in to post comments.

We care about your feedback. Let us know how we can improve your CancerCompass experience.